Mauro C, Leow SC, Anso E, Rocha S, Thotakura AK, Tornatore L, Moretti M, De Smaele E,
Beg AA, Tergaonkar V, Chandel NS, Franzoso G (2011) NF-kappaB controls energy homeo-
stasis and metabolic adaptation by upregulating mitochondrial respiration. Nat Cell Biol
13:1272–1279
Johnson RF, Perkins ND (2012) Nuclear factor-kappaB, p53, and mitochondria: regulation of
cellular metabolism and the Warburg effect. Trends Biochem Sci 37:317–324
Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP, Baldwin AS (2008) Akt-dependent
regulation of NF-{kappa} B is controlled by mTOR and raptor in association with IKK. Genes
Dev 22:1490–1500
Adamson AL, Le BT, Siedenburg BD (2014) Inhibition of mTORC1 inhibits lytic replication
of Epstein-Barr virus in a cell-type specific manner. Virol J 11:110
Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18:1926–1945
Shimobayashi M, Hall MN (2014) Making new contacts: the mTOR network in metabolism
and signalling crosstalk. Nat Rev Mol Cell Biol 15:155–162
Chen J, Hu CF, Hou JH, Shao Q, Yan LX, Zhu XF, Zeng YX, Shao JY (2010) Epstein-Barr
virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which
predict poor prognosis of nasopharyngeal carcinoma. J Transl Med 8:30
Pusapati RV, Daemen A, Wilson C, Sandoval W, Gao M, Haley B, Baudy AR, Hatzivassiliou
G, Evangelista M, Settleman J (2016) mTORC1-dependent metabolic reprogramming under-
lies escape from glycolysis addiction in cancer cells. Cancer Cell 29:548–562
Garcia-Cao I, Song MS, Hobbs RM, Laurent G, Giorgi C, de Boer VC, Anastasiou D, Ito K,
Sasaki AT, Rameh L, Carracedo A, Vander Heiden MG, Cantley LC, Pinton P, Haigis MC,
Pandolfi PP (2012) Systemic elevation of PTEN induces a tumor-suppressive metabolic state.
Cell 149:49–62
Edwards RH, Marquitz AR, Raab-Traub N (2015) Changes in expression induced by Epstein-
Barr virus LMP1-CTAR1: potential role of bcl3. MBio 6:e00441
Xiao L, Hu ZY, Dong X, Tan Z, Li W, Tang M, Chen L, Yang L, Tao Y, Jiang Y, Li J, Yi B, Li
B, Fan S, You S, Deng X, Hu F, Feng L, Bode AM, Dong Z, Sun LQ, Cao Y (2014) Targeting
Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carci-
noma to radiation therapy. Oncogene 33:4568–4578
Cai L, Ye Y, Jiang Q, Chen Y, Lyu X, Li J, Wang S, Liu T, Cai H, Yao K, Li JL, Li X (2015)
Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating
PTEN-dependent pathways in nasopharyngeal carcinoma. Nat Commun 6:7353
Lo AK, Lo KW, Ko CW, Young LS, Dawson CW (2013) Inhibition of the LKB1-AMPK path-
way by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of
human nasopharyngeal epithelial cells. J Pathol 230:336–346
Lu J, Tang M, Li H, Xu Z, Weng X, Li J, Yu X, Zhao L, Liu H, Hu Y, Tan Z, Yang L, Zhong M,
Zhou J, Fan J, Bode AM, Yi W, Gao J, Sun L, Cao Y (2016) EBV-LMP1 suppresses the DNA
damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopha-
ryngeal carcinoma. Cancer Lett 380:191–200
McFadden K, Hafez AY, Kishton R, Messinger JE, Nikitin PA, Rathmell JC, Luftig MA (2016)
Metabolic stress is a barrier to Epstein–Barr virus-mediated B-cell immortalization. Proc Natl
Acad Sci 113:E782–E790
Verhoeven RJ, Tong S, Zhang G, Zong J, Chen Y, Jin DY, Chen MR, Pan J, Chen H (2016)
NF-kappaB signaling regulates expression of Epstein-Barr virus BART MicroRNAs and long
noncoding RNAs in nasopharyngeal carcinoma. J Virol 90:6475–6488
Marquitz AR, Raab-Traub N (2012) The role of miRNAs and EBV BARTs in NPC. Semin
Cancer Biol 22:166–172
Klinke O, Feederle R, Delecluse HJ (2014) Genetics of Epstein-Barr virus microRNAs. Semin
Cancer Biol 26:52–59
Jung YJ, Choi H, Kim H, Lee SK (2014) MicroRNA miR-BART20-5p stabilizes Epstein-Barr
virus latency by directly targeting BZLF1 and BRLF1. J Virol 88:9027–9037
